. Within TheraDoc, each AS program designed alerts and interventions specific to its own medical center and collaborated to develop a group of 22 interventions that were shared by all sites. There was no attempt to alter individually determined AS practices of each VAMC.
Conclusion. Working collaboratively allowed each VAMC to leverage shared resources. Each AS program was able to adapt to its VAMC's specific needs, while also demonstrating significant aggregate cost savings as a result of coordinated and defined AS activities.
Disclosures. M. Zuzick, Document Storage Systems: Employee, Salary. J. Chang, Document Storage Systems: Employee, Salary. Background. Telemedicine (TM) programs have been effectively implemented to deliver specialty care through virtual platforms to overcome geographic and resource constraints. Yet, few data exist to describe outcomes associated with TM-based management of patients with infectious diseases (ID). The purpose of this study was to compare adherence and other outcomes associated with TM and on-site (SOC) ID consultation (IDC) implementation strategies of an antimicrobial stewardship (ASP)-led S. aureus bacteremia (SAB) bundle.
Successful Use of Telemedicine vs. On-site Infectious Diseases Consultation
Methods. We launched an SAB bundle at 10 acute care hospitals in the metro Charlotte, NC area in September 2016 for adult patients admitted with SAB and conducted a retrospective cohort study using data collected through 2017. Bundle components included (1) mandatory IDC, (2) appropriate antibiotics within 24 hours of S. aureus speciation, (3) repeat blood cultures at least every 72 hours until clearance, (4) obtainment of an echocardiogram, and (5) appropriate duration of intravenous antibiotic therapy based on SAB severity. ASP facilitated bundle initiation and assisted with compliance for all patients. The primary outcome was bundle adherence. Secondary outcomes included time to culture clearance and persistent SAB (i.e., positive blood cultures for >7 days). We used Wilcoxon rank-sum and chi-squared tests to compare outcomes.
Results. We evaluated 872 patients with SAB during the study interval. After excluding 126 patients (prematurely discharged or died/transitioned to comfort care within 48 hours of S. aureus speciation), we analyzed 583 SOC and 163 TM group patients. There were no differences observed in overall SAB bundle adherence (SOC 86% vs. TM 88%, P = 0.52), or its individual components. No differences were found in time to culture clearance (median days: SOC = 2.9 vs. TM = 2.8, P = 0.96) and persistent SAB (SOC 11% vs. TM 11%, P = 0.77).
Conclusion. Our findings provide preliminary evidence to support TM-based strategies for IDC and ASP-led care bundles in resource-limited settings. Future analyses will compare mortality and hospital readmission outcomes.
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No reported disclosures. Methods. The remote clinical pharmacist performed a gap analysis to identify areas requiring improvement for a successful ASP which included the need for an Antimicrobial Stewardship committee, an IV to PO conversion program for antibiotics, development of guidelines and clinical pathways for common infections, hospital specific antibiogram, and prospective audit with intervention and feedback. The remote clinical pharmacist participated in meetings with nurses, physicians, and other key stakeholders using videoconference technology to develop a plan for the ASP. The remote clinical pharmacist started prospective data collection in September 2013. Starting January 2014, the remote clinical pharmacists started providing prospective audit with intervention and feedback.
Telepharmacy Support of an Antimicrobial Stewardship Program in a Small
Results. The antimicrobial stewardship program was formally accepted by Accreditation Canada in December 2013. Methods. Cohort study of patients hospitalized with community-acquired pneumonia (CAP) or healthcare-associated pneumonia (HCAP) between November 2015 and January 2018 at 48 hospitals participating in the Michigan Hospital Medicine Safety consortium. Adult, non-ICU, medical patients were included. Patients with concomitant infections, severe immunosuppression, or unusual pathogens were excluded. Detailed patient data, included duration of antibiotic treatment, were abstracted from the medical record. Appropriate duration was calculated for each patient based on time to clinical stability, organism, and comorbidities. Patient outcomes included mortality, readmission, length of stay, transfer to intensive care, and Clostridium difficile infection. Disease-, patient-, provider-, and hospital-factors associated with excess antibiotic duration and association of excess duration with patient outcomes were evaluated using multivariable generalized estimating equations models.
Excess Antibiotic Duration in Patients Hospitalized

